Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424

Article  PubMed  Google Scholar 

Valastyan S, Weinberg RA (2011) Tumor metastasis: molecular insights and evolving paradigms. Cell 147(2):275–292

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hess KR, Varadhachary GR, Taylor SH, Wei W, Raber MN, Lenzi R, Abbruzzese JL (2006) Metastatic patterns in adenocarcinoma. Cancer 106(7):1624–1633

Article  PubMed  Google Scholar 

Sakorafas GH, Tsiotou AG (2000) Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives. Cancer Treat Rev 26(2):103–125

Article  CAS  PubMed  Google Scholar 

Erin N, Kale S, Tanriover G, Koksoy S, Duymus O, Korcum AF (2013) Differential characteristics of heart, liver, and brain metastatic subsets of murine breast carcinoma. Breast Cancer Res Treat 139(3):677–689

Article  CAS  PubMed  Google Scholar 

Erin N, Ogan N, Yerlikaya A (2018) Secretomes reveal several novel proteins as well as TGF-beta1 as the top upstream regulator of metastatic process in breast cancer. Breast Cancer Res Treat 170(2):235–250

Article  CAS  PubMed  Google Scholar 

Erin N, Podnos A, Tanriover G, Duymus O, Cote E, Khatri I, Gorczynski RM (2015) Bidirectional effect of CD200 on breast cancer development and metastasis, with ultimate outcome determined by tumor aggressiveness and a cancer-induced inflammatory response. Oncogene 34(29):3860–3870

Article  CAS  PubMed  Google Scholar 

Erin N, Tanriover G, Curry A, Akman M, Duymus O, Gorczynski R (2018) CD200fc enhances anti-tumoral immune response and inhibits visceral metastasis of breast carcinoma. Oncotarget 9(27):19147–19158

Article  PubMed  PubMed Central  Google Scholar 

Erin N, Dilmac S, Curry A, Duymus O, Tanriover G, Prodeus A, Gariepy J, Gorczynski RM (2020) CD200 mimetic aptamer PEG-M49 markedly increases the therapeutic effects of pegylated liposomal doxorubicin in a mouse model of metastatic breast carcinoma: an effect independent of CD200 receptor 1. Cancer Immunol Immunother 69(1):103–114

Article  CAS  PubMed  Google Scholar 

Nizam E, Koksoy S, Erin N (2020) NK1R antagonist decreases inflammation and metastasis of breast carcinoma cells metastasized to liver but not to brain; phenotype-dependent therapeutic and toxic consequences. Cancer Immunol Immunother 69(8):1639–1650

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schrors B, Boegel S, Albrecht C, Bukur T, Bukur V, Holtstrater C, Ritzel C, Manninen K, Tadmor AD, Vormehr M et al (2020) Multi-omics characterization of the 4T1 murine mammary gland tumor model. Front Oncol 10:1195

Article  PubMed  PubMed Central  Google Scholar 

Dillekas H, Rogers MS, Straume O (2019) Are 90% of deaths from cancer caused by metastases? Cancer Med 8(12):5574–5576

Article  PubMed  PubMed Central  Google Scholar 

Erin N, Nizam E, Tanriover G, Koksoy S (2015) Autocrine control of MIP-2 secretion from metastatic breast cancer cells is mediated by CXCR2: a mechanism for possible resistance to CXCR2 antagonists. Breast Cancer Res Treat 150(1):57–69

Article  CAS  PubMed  Google Scholar 

Aslakson CJ, Miller FR (1992) Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 52(6):1399–1405

CAS  PubMed  Google Scholar 

Sulaiman A, McGarry S, Chilumula SC, Kandunuri R, Vinod V (2021) Clinically translatable approaches of inhibiting TGF-beta to target cancer stem cells in TNBC. Biomedicines. https://doi.org/10.3390/biomedicines9101386

Article  PubMed  PubMed Central  Google Scholar 

Du F, Li J, Zhong X, Zhang Z, Zhao Y (2024) Endothelial-to-mesenchymal transition in the tumor microenvironment: roles of transforming growth factor-beta and matrix metalloproteins. Heliyon 10(21):e40118

Article  CAS  PubMed  PubMed Central  Google Scholar 

Giarratana AO, Prendergast CM, Salvatore MM, Capaccione KM (2024) TGF-beta signaling: critical nexus of fibrogenesis and cancer. J Transl Med 22(1):594

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang H, Tang Q, Li S, Qin Y, Zhu G (2024) TGFBI: A novel therapeutic target for cancer. Int Immunopharmacol 134:112180

Article  CAS  PubMed  Google Scholar 

Liu GL, Yang HJ, Liu T, Lin YZ (2014) Expression and significance of E-cadherin, N-cadherin, transforming growth factor-beta1 and Twist in prostate cancer. Asian Pac J Trop Med 7(1):76–82

Article  CAS  PubMed  Google Scholar 

Bierie B, Moses HL (2010) Transforming growth factor beta (TGF-beta) and inflammation in cancer. Cytokine Growth Factor Rev 21(1):49–59

Article  CAS  PubMed  Google Scholar 

Sheen YY, Kim MJ, Park SA, Park SY, Nam JS (2013) Targeting the transforming growth factor-beta signaling in cancer therapy. Biomol Ther (Seoul) 21(5):323–331

Article  CAS  PubMed  Google Scholar 

Padua D, Massague J (2009) Roles of TGFbeta in metastasis. Cell Res 19(1):89–102

Article  CAS  PubMed  Google Scholar 

Katz LH, Li Y, Chen JS, Munoz NM, Majumdar A, Chen J, Mishra L (2013) Targeting TGF-beta signaling in cancer. Expert Opin Ther Targets 17(7):743–760

Article  CAS  PubMed  PubMed Central  Google Scholar 

Anastasi C, Rousselle P, Talantikite M, Tessier A, Cluzel C, Bachmann A, Mariano N, Dussoyer M, Alcaraz LB, Fortin L et al (2020) BMP-1 disrupts cell adhesion and enhances TGF-beta activation through cleavage of the matricellular protein thrombospondin-1. Sci Signal. https://doi.org/10.1126/scisignal.aba3880

Article  PubMed  Google Scholar 

da Silva R, Uno M, Marie SK, Oba-Shinjo SM (2015) LOX expression and functional analysis in astrocytomas and impact of IDH1 mutation. PLoS ONE 10(3):e0119781

Article  PubMed  PubMed Central  Google Scholar 

Hsieh YY, Tung SY, Pan HY, Yen CW, Xu HW, Deng YF, Lin YJ, Hsu WT, Wu CS, Li C (2018) Upregulation of bone morphogenetic protein 1 is associated with poor prognosis of late-stage gastric Cancer patients. BMC Cancer 18(1):508

Article  PubMed  PubMed Central  Google Scholar 

Xiao W, Wang X, Wang T, Xing J (2020) Overexpression of BMP-1 reflects poor prognosis in clear cell renal cell carcinoma. Cancer Gene Ther 27(5):330–340

Article  CAS  PubMed  Google Scholar 

Vadon-Le Goff S, Hulmes DJ, Moali C (2015) BMP-1/tolloid-like proteinases synchronize matrix assembly with growth factor activation to promote morphogenesis and tissue remodeling. Matrix Biol 44–46:14–23

Article  PubMed  Google Scholar 

Delolme F, Anastasi C, Alcaraz LB, Mendoza V, Vadon-Le Goff S, Talantikite M, Capomaccio R, Mevaere J, Fortin L, Mazzocut D et al (2015) Proteolytic control of TGF-beta co-receptor activity by BMP-1/tolloid-like proteases revealed by quantitative iTRAQ proteomics. Cell Mol Life Sci 72(5):1009–1027

Article  CAS  PubMed  Google Scholar 

Ge G, Greenspan DS (2006) BMP-1 controls TGFbeta1 activation via cleavage of latent TGFbeta-binding protein. J Cell Biol 175(1):111–120

Article  CAS  PubMed  PubMed Central